PURE Bioscience, Inc.: revenue
Revenue for PURE Bioscience, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All PURE Bioscience, Inc. financial histories
What this measure means
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
Exact concept: us-gaap:Revenues. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-08-01 to 2025-07-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-08-01 | 2025-07-31 | 2,198,000 | USD | 2025-10-29 | 10-K · 0001493152-25-020065 |
| 2023-08-01 | 2024-07-31 | 1,955,000 | USD | 2025-10-29 | 10-K · 0001493152-25-020065 |
| 2022-08-01 | 2023-07-31 | 1,871,000 | USD | 2024-10-29 | 10-K · 0001493152-24-042939 |
| 2021-08-01 | 2022-07-31 | 1,813,000 | USD | 2023-10-30 | 10-K · 0001493152-23-038673 |
| 2020-08-01 | 2021-07-31 | 3,698,000 | USD | 2022-10-28 | 10-K · 0001493152-22-029844 |
| 2019-08-01 | 2020-07-31 | 6,917,000 | USD | 2021-10-28 | 10-K · 0001493152-21-026623 |
| 2011-08-01 | 2012-07-31 | 812,000 | USD | 2012-10-29 | 10-K · 0001079973-12-000838 |
| 2010-08-01 | 2011-07-31 | 464,000 | USD | 2012-10-29 | 10-K · 0001079973-12-000838 |
Related financial histories
- PURE Bioscience, Inc.: total assets
- PURE Bioscience, Inc.: total liabilities
- PURE Bioscience, Inc.: stockholders equity
- PURE Bioscience, Inc.: cash and cash equivalents
- PURE Bioscience, Inc.: net income or loss
- PURE Bioscience, Inc.: operating cash flow
- PURE Bioscience, Inc.: capital expenditure payments
- PURE Bioscience, Inc.: contract revenue excluding tax
- PURE Bioscience, Inc.: financing cash flow
- PURE Bioscience, Inc.: investing cash flow
- PURE Bioscience, Inc.: retained earnings or deficit
- PURE Bioscience, Inc.: basic weighted-average shares
- PURE Bioscience, Inc.: diluted weighted-average shares
- PURE Bioscience, Inc.: basic earnings per share
- PURE Bioscience, Inc.: diluted earnings per share
- PURE Bioscience, Inc.: income tax expense or benefit
- PURE Bioscience, Inc.: net property, plant and equipment
- PURE Bioscience, Inc.: share-based compensation expense
- PURE Bioscience, Inc.: operating income or loss
- PURE Bioscience, Inc.: current assets
- PURE Bioscience, Inc.: interest expense
- PURE Bioscience, Inc.: current liabilities
- PURE Bioscience, Inc.: current accounts payable
- PURE Bioscience, Inc.: net finite-lived intangible assets
- PURE Bioscience, Inc.: net current accounts receivable
- PURE Bioscience, Inc.: operating expenses
- PURE Bioscience, Inc.: net inventory
- PURE Bioscience, Inc.: gross profit
- PURE Bioscience, Inc.: selling, general and administrative expense
- PURE Bioscience, Inc.: research and development expense
Inspect the source
- Entity
- PURE Bioscience, Inc. / CIK 0001006028
- Captured
- 2026-09-20T05:11:57.608Z
- SEC response SHA-256
592f8793cc81bf26bc4a9a52fc6040155bd07f864b81db91b56963966a8209f2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001006028.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))